Journals / Respiratory Case Reports / 2016 / Cilt: 5 - Sayı: 3

Large cell neuroendocrine carcinoma of lung with early chest wall metastasis

Erken dönem göğüs duvarı metastazı oluşturan akciğerin büyük hücreli nöroendokrin karsinomu

Pages
204–208
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Accurate differen- tiation of LCNEC from other types of NSCLC is im- portant, and there is a need for close follow-up in these patients for aggressive and metastatic nature and recurrent disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The large cell neuroendocrine carcinomas of the lung (LCNEC) are high-grade tumors and they have simi- lar clinical and biological characteristics of non-small cell lung cancer (NSCLC).
📊
Key Findings & Data:Sixty-two-year-old male patient had a 1.5 cm solid mass in left upper lob on computered tomogra- phy (CT).
💡
Conclusion & Impact:Accurate differen- tiation of LCNEC from other types of NSCLC is im- portant, and there is a need for close follow-up in these patients for aggressive and metastatic nature and recurrent disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The large cell neuroendocrine carcinomas of the lung (LCNEC) are high-grade tumors and they have simi- lar clinical and biological characteristics of non-small cell lung cancer (NSCLC). We discuss a patient with LCNEC of the lung which early metastasis to chest wall. Sixty-two-year-old male patient had a 1.5 cm solid mass in left upper lob on computered tomogra- phy (CT). The mass was reported by positron emis- sion tomography as malignant. Left upper lobectomy was applied in the same period, when perioperatively frozen-section result was diagnosed NSLC. Histo- pathological examination was revealed a neuroendo- crine carcinoma, which may originate from the gas- trointestinal tract p(T1AN0M0). The octreotide scin- tigraphy, gastroscopy, colonoscopy, abdominal, and chest CT were performed for primary origin, but did not reveal any pathology. Chest wall mass was de- tected postoperative third months and biopsy result was reported as large cell neuroendocrine carcino- ma. Then, chemoradiotherapy was planned. Patient died after one year from diagnosis. Accurate differen- tiation of LCNEC from other types of NSCLC is im- portant, and there is a need for close follow-up in these patients for aggressive and metastatic nature and recurrent disease.

Özet

Akciğerin büyük hücreli nöroendokrin karsinomları (BHNK) yüksek gradeli tümörlerdir ve küçük hücreli akciğer kanserine(KHAK) benzer klinik ve biyolojik özellikler taşırlar. Erken dönem göğüs duvarı metas- tazı oluşturan akciğerin bir BHNK'li olguyu tartışmayı amaçladık. Altmış iki yaşında erkek hastanın toraks bilgisayarlı tomografisinde (BT) sol akciğer üst lob anterior segmentte 1,5 cm solid kitle izlendi. Pozitron emisyon tomografisinde kitle malign karakterdeydi. Peroperatuvar frozen sonucu; küçük hücreli dışı akci- ğer kanseri (KHDAK) gelmesi üzerine sol üst lobekto- mi uygulandı. Sonuç gastrointestinal sistem kaynaklı p(T1aN0M0) nöroendokrin karsinom olarak rapor- landı. Primer kaynağa yönelik yapılan oktreotid sintig- rafisi, gastroskopi, kolonoskopi, batın-toraks BT'de bir patoloji saptanmadı. Olgunun 3. ay kontrolünde; göğüs duvarında kitle tespit edildi ve alınan biyopsi BHNK metastazı olarak raporlandı. Olguya kemo- radyoterapi planlandı. Olgu tanıdan bir yıl sonra kaybedildi. BHNK'ler hızlı metastaz yapabilen, agresif seyirli, nüks edebilen tümörler oldukları için diğer KHDAK'lerinden ayrılması önemlidir, bu hastalarda yakından takibe ihtiyaç vardır

🔖

Cite This Article

YANIK, F., KARAMUSTAFAOĞLU, Y. A., KARATAŞ, A., TAŞTEKİN, E. (2016). Large cell neuroendocrine carcinoma of lung with early chest wall metastasis. Respiratory Case Reports, Cilt: 5 - Sayı: 3, 204–208. https://ajindex.com/articles/302569

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Mougey AM, Adler DG. Neuroendocrine tumors: Review and clinical update. Hospital Physician 2007; 51:12-20.
  2. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading and staging systems. Pancreas 2010; 39:707-12. [CrossRef] Moran CA, Suster S, Coppola D, Wick MR. Neuroendoc- rine carcinomas of the lung. Am J Clin Pathol 2009; 131:206-21.
  3. Hage R, Seldenrijk K, de Bruin P, van Swieten H, van den Bosch J. Pulmonary large-cell neuroendocrine carcinoma (LCNEC). Eur J Cardiothorac Surg 2003; 23: 457-60. [CrossRef] Cerilli LA, Ritter JH, Mills SE, Wick MR. Neuroendocrine neoplasms of the lung. Am J Clin Pathol 2001; 116:S65- 96. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, et al. The 2015 World Health Organiza- tion classification of lung tumors: impact of genetic, clini- cal and radiologic advances since the 2004 classification. J Thorac Oncol 2015; 10:1243-60. [CrossRef] Travis WD. The 2015 WHO classification of lung tumors. Pathologe 2014; 35 Suppl 2:188. [CrossRef] Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R, Koss MN. Reproducibility of neuroendocrine lung tumor classi- fication. Hum Pathol 1998; 29:272-9. [CrossRef] Rekhtman N. Neuroendocrine tumors of the lung: an up- date. Arch Pathol Lab Med 2010; 134:1628-38. [CrossRef] Garcia-Yuste M, Matilla JM, Alvarez-Gago T, Duque JL, Heras F, Cerezal LJ, et al. Prognostic factors in neuroen- docrine lung tumors: a Spanish multicenter study. Spa- nish multicenter study of neuroendocrine tumors of the lung of the Spanish Society of Pneumonology and Thora- cic Surgery. Ann Thorac Surg 2000; 70: 258-63.
  4. Paci M, Cavazza A, Annessi V, Putrino I, Ferrari G, De Franco S, et al. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg 2004; 77:1163-7. [CrossRef] Miller VA1, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, et al. Bronchioloalveolar pathologic subtype and smo- king history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 2004; 22:1103-9. [CrossRef] Doddoli C, Barlesi F, Chetaille B, Garbe L, Thomas P, Giudicelli R, et al. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery. Ann Thorac Surg 2004; 77:1168-72. [CrossRef] Akciğer karsinomlarının patolojisi. Göğüs Cerrahisi, Ök- ten İ, Kavukçu HŞ, Ed. 2. Baskı, İstanbul: İstanbul Tıp Ki- tapevi; 2013:1045-72